(Q38962069)

8 September 2017

title

HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma (English)

1 reference

8 September 2017

Qingbing Meng

1

1 reference

8 September 2017

Jie Zhao

2

1 reference

8 September 2017

Hongbing Liu

3

1 reference

8 September 2017

Guoyou Zhou

4

1 reference

8 September 2017

Wensheng Zhang

5

1 reference

8 September 2017

Xingli Xu

6

1 reference

8 September 2017

Minqian Zheng

7

1 reference

8 September 2017

publication date

29 August 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

12265-12274

1 reference

TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Bone tumors in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Defining the epithelial stem cell niche in skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Stem cells find their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

The association of HMGB1 gene with the prognosis of HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

HMGB1 in hormone-related cancer: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Role and regulation of β-catenin signaling during physiological liver growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Evaluating cytoplasmic and nuclear levels of inflammatory cytokines in cancer cells by western blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

The role of high mobility group box 1 (HMGB1) in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2535-3

Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells

21 January 2018

1 reference

12 December 2020

[Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells]

1 reference

12 December 2020

Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo

1 reference

12 December 2020

Molecular mechanisms of chemoresistance in osteosarcoma (Review).

1 reference

12 December 2020

Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P‑glycoprotein expression in gastric adenocarcinoma cells

1 reference

12 December 2020

Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.

1 reference

12 December 2020

Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo

1 reference

12 December 2020

Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis

1 reference

12 December 2020

[Expression of HMGB1 protein in laryngeal squamous cell carcinoma and its clinical significance]

1 reference

12 December 2020

[Effects of high mobility group box-1 silencing upon the invasion and proliferation in human lung cancer cell L9981 by RNA inhibition].

1 reference

12 December 2020

HMGB1 is a therapeutic target for leukemia.

1 reference

12 December 2020

[HMGB1-a as potential target for therapy of hematological malignancies]

1 reference

12 December 2020

Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells

1 reference

12 December 2020

Osteosarcoma of the femur with skip, lymph node, and lung metastases

1 reference

12 December 2020

Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0090396

Identifiers

DOI

10.1007/S13277-014-2535-3

1 reference

Dimensions Publication ID

8 September 2017

1051601666

0 references

1 reference